On September 14, 2024, BioCity presented interim clinical results on the safety and efficacy of its first-in-class antibody-drug conjugate (ADC) BC3195 targeting CDH3 (P-Cadherin) in a Phase I...

Pitching Challenge to Reward Companies with United States Pilot and Funding Opportunities DALLAS, Sept. 23, 2024 /PRNewswire/ -- North Texas Innovation Alliance (NTXIA), a 501(c)3 regional...

The 2024 International Low-altitude Economy Product Release and Investment Conference was successfully held in Chengdu, a city with passion, where attracted the global attention of low-altitude...

At the Automechanika Frankfurt 2024, HONGQI launched its latest new energy vehicles —the EH7 all-electric sedan and the EHS7 all-electric SUV. This marked HONGQI's second appearance at...

Trade Estonia, part of Enterprise Estonia, is concluding its participation at the ITS World Congress 2024 in Dubai, further asserting its leadership in intelligent transport systems (ITS) and...